Skip to main content

Advertisement

Figure 3 | Nutrition & Metabolism

Figure 3

From: Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats

Figure 3

Lactobacillus reuteri GMNL-263 improves liver injury and oxidative stress in high-fructose-diet rats. Effects of Lactobacillus reuteri GMNL-263 on expressions of liver injury markers (AST and ALT) (A), hepatic enzymatic activities of antioxidant (SOD and GR) (B), and pro-inflammatory cytokines (TNF-α and IL-6) (C) in high-fructose-diet rats at the end of the experimental period (14 weeks). The data were expressed as mean ± SD (n = 6). SOD, speroxide dismutase; GR, glutathione reductase. AST, aspartate aminotransferase; ALT, alanine aminotransferase; TNF-α, tumor necrosis factorα; IL-6, interleukin 6. #p < 0.05 compared with Control group; *p < 0.05 compared with HFD group.

Back to article page